Alba Sulaj

Dr. Alba Sulaj is a Clinical Professor and Deputy Medical Director at Heidelberg University Hospital's Department of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry. She holds multiple leadership roles including Acting Section Head of Osteology and Medical Director of the General Endocrinology Outpatient Clinic. Her work focuses on metabolic diseases, diabetes complications, and the therapeutic potential of fasting interventions. Dr. Sulaj completed her medical training at Heidelberg University and has been actively involved in clinical and translational research since 2005. She leads studies on lifestyle interventions, diabetic nephropathy, and obesity management, with funding from the German Center for Diabetes Research (DZD) and other institutions. Her research has been recognized with awards including the Silvia-King-Preis (2023) and DZD NEXT Fellowship (2019). She also contributes to the development of novel diagnostic methods and clinical protocols in endocrinology.

Research Interests:

• Diabetes pathophysiology and complications
• Metabolic effects of fasting and intermittent energy restriction
• Obesity and metabolic syndrome management
• Diabetic kidney disease mechanisms and therapies
• Novel biomarker development in endocrinology

Recent studies highlight her work on fasting-based interventions for type 2 diabetes patients and the role of inflammatory pathways in diabetic nephropathy. She has published extensively in journals such as Cell Metabolism and Nature Communications.